Economic Indicators - Initial Jobless Claims rose to 241K, exceeding the expected 225K and the revised previous week's 223K, marking the highest level since February [3] - Continuing Claims surpassed 1.9 million, reaching 1.916 million, the highest since November 2021, indicating potential labor market weakness [4] Q1 Earnings Reports - Eli Lilly (LLY) reported earnings of $3.34 per share, missing expectations by 5%, but revenues of $12.73 billion exceeded projections and last year's $8.77 billion, driven by strong sales of the weight-loss drug Mounjaro [5] - McDonald's (MCD) posted earnings of $2.67 per share, slightly above consensus, but revenues of $5.96 billion missed expectations, with same-store sales at their lowest in five years [6] - CVS Health (CVS) beat earnings expectations with $2.25 per share, a 31.6% surprise, and revenues of $94.59 billion, up 1.76% from estimates, contributing to a 48% year-to-date gain [7] - Wayfair (W) reported a surprise profit of $0.10 per share, compared to an expected loss of $0.18, with revenues of $2.73 billion slightly above estimates, leading to a 6% increase in shares [8] Market Expectations - Anticipation for S&P Manufacturing PMI and ISM Manufacturing data, with S&P expected to slightly decrease to 50.6, while ISM is projected to drop to 47.8, indicating potential contraction [9] - Construction Spending for March is expected to decline to +0.2% from +0.7% in February, reflecting potential shifts in trade policy [10] Upcoming Earnings - Amazon (AMZN) and Apple (AAPL) are set to report Q1 earnings after the market closes, along with other companies like Mastercard (MA), Amgen (AMGN), and Twilio (TWLO) [11]

CVS Health Corporation (CVS) is scheduled to report first-quarter 2025 results on May 1, before the opening bell. 3 Factors to Focus on Ahead of CVS' Q1 Earnings A Turnaround at Aetna Expected: Aetna's underperformance in 2024 was concerning. However, CVS expected benefit redesigns and improved rate negotiations to lead to margin recovery starting from 2025. While utilization trends remained elevated in the fourth quarter of 2024, data showed moderation in inpatient costs, a positive sign for medical cost c ...